The COronaVirus DISease 19 (COVID-19) is a pandemic infectious disease caused by the novel coronavirus Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2). Older age and presence of comorbidities, including diabetes, were shown to be associated with a more severe course and a higher fatality rate. Studies from the most affected countries, including China, United States and Italy, seem to indicate that prevalence of diabetes among patients affected by COVID-19 is not higher than that observed in the general population, thus suggesting that diabetes is not a risk factor for SARS-CoV-2 infection. However, a large body of evidence demonstrate that diabetes is a risk factor for disease progression towards critical illness, development of acute respiratory distress syndrome, need for mechanical ventilation or admission to intensive care unit, and ultimately death. The mechanisms underlying the relationship between COVID-19 and diabetes remain to be elucidated. In particular, it is still unresolved whether is diabetes per se, especially if poorly controlled, or rather the various comorbidities/complications associated with it that predispose patients with COVID-19 to a worse prognosis. In fact, conditions that cluster with diabetes in the context of the metabolic syndrome, such as obesity and hypertension, or complicate chronic hyperglycemia, such as cardiovascular disease and chronic kidney disease, have also been associated with poor prognosis in these individuals and the available studies have not consistently shown that diabetes predict disease severity independently of them.

Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)? / Pugliese, G.; Vitale, M.; Resi, V.; Orsi, E.. - In: ACTA DIABETOLOGICA. - ISSN 0940-5429. - 57:11(2020), pp. 1275-1285. [10.1007/s00592-020-01586-6]

Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?

Pugliese G.
Primo
;
Vitale M.
Secondo
;
2020

Abstract

The COronaVirus DISease 19 (COVID-19) is a pandemic infectious disease caused by the novel coronavirus Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2). Older age and presence of comorbidities, including diabetes, were shown to be associated with a more severe course and a higher fatality rate. Studies from the most affected countries, including China, United States and Italy, seem to indicate that prevalence of diabetes among patients affected by COVID-19 is not higher than that observed in the general population, thus suggesting that diabetes is not a risk factor for SARS-CoV-2 infection. However, a large body of evidence demonstrate that diabetes is a risk factor for disease progression towards critical illness, development of acute respiratory distress syndrome, need for mechanical ventilation or admission to intensive care unit, and ultimately death. The mechanisms underlying the relationship between COVID-19 and diabetes remain to be elucidated. In particular, it is still unresolved whether is diabetes per se, especially if poorly controlled, or rather the various comorbidities/complications associated with it that predispose patients with COVID-19 to a worse prognosis. In fact, conditions that cluster with diabetes in the context of the metabolic syndrome, such as obesity and hypertension, or complicate chronic hyperglycemia, such as cardiovascular disease and chronic kidney disease, have also been associated with poor prognosis in these individuals and the available studies have not consistently shown that diabetes predict disease severity independently of them.
2020
cardiovascular disease; chronic kidney disease; covid-19; diabetes; hypertension; obesity; betacoronavirus; covid-19; comorbidity; disease progression; humans; prognosis; risk factors; sars-CoV-2; Severity of Illness Index; Coronavirus Infections; Diabetes Complications; Diabetes Mellitus; Pandemics; Pneumonia, Viral
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)? / Pugliese, G.; Vitale, M.; Resi, V.; Orsi, E.. - In: ACTA DIABETOLOGICA. - ISSN 0940-5429. - 57:11(2020), pp. 1275-1285. [10.1007/s00592-020-01586-6]
File allegati a questo prodotto
File Dimensione Formato  
Pugliese_Is-diabetes-mellitus_2020.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 667.28 kB
Formato Adobe PDF
667.28 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1474634
Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 44
  • ???jsp.display-item.citation.isi??? 37
social impact